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Objectives. This study assessed changes in coronary flow veloc- 
ity measured distal to a significant stenosis of the left anterior 
descending coronary artery and at the adjacent normal left 
circumflex coronary artery, produced by intravenous administra- 
tion of dipyridamole, in patients undergoing coronary angioplasty 
with a documented perfusion defect on dipyridamole-thallium- 
201 scintigraphy. 
Background. Significant flow inhomogeneity is believed to de- 
velop during coronary vasodilation induced by dipyridamole, 
causing a defect in the thallium-201 scintigram. The recently 
developed intracoronary Doppler guide wire permits assessment 
of flow velocity variables in normal and stenotic arteries. 
Methods. In 17 patients with stable angina we studied changes 
in time-averaged peak velocity and the diastolic/systolic velocity 
ratio simultaneously using two 0.014-in. (0.36-ram) Doppler guide 
wires at baseline and after 4 min of dipyridamole infusion 
(0.56 mg/kg body weight). Coronary flow velocity reserve and 
relative flow reserve were correlated with the degree of stenosis on 
coronary angiography and quantitative analysis of thallium-201 
images. 
Results. No change in distal flow velocity was observed in the 
stenotic vessel (5.5 ± 33.7% [mean ± SD]), in contrast to a sig- 
nificant increase observed in the adjacent normal vessel (162.4 ± 
39.8%). Poststenotic oronary flow velocity reserve correlated with 
percent lumen diameter stenosis (r = -0.66, p < 0.05). A 
correlation was also observed between the relative flow reserve/ 
thallium-201 relative perfusion ratio (r = 0.90, p < 0.001). 
Conclusions. To our knowledge, these findings represent the 
first direct proof of dipyridamole-indueed flow inhomogeneity 
producing a perfusion defect on thallium-201 imaging. The degree 
of inhomogeneity is related to the extent of the perfusion defect. 
(JAm Coll Cardio11996;27:1148-55) 
Intravenous dipyridamole has been used to produce coronary 
vasodilation i the context of a variety of cardiac imaging proce- 
dures, such as thallium-201 scintigraphy, two-dimensional echo- 
cardiography and positron emission tomography (1-7). Various 
techniques, such as thermodilution-estimated coronary sinus 
blood flow, digital subtraction angiography, intracoronary Dopp- 
ler measurements and positron emission tomography, have been 
applied to measure coronary blood flow in humans (8-15). 
However, these techniques cannot reliably measure differences of
flow across a stenosis. Recently it has become possible to assess 
the intracoronary flow velocity directly proximal and distal to a 
stenosis in humans using a Doppler-tipped flexible guide wire 
(16,17). 
In the present study we utilized the Doppler guide wire with 
the aim of comparing the changes in coronary flow velocity 
measured simultaneously 1) at a segment distal to a significant 
stenosis, and 2) at an adjacent normal coronary artery pro- 
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duced by the intravenous administration of dipyridamole in
patients undergoing coronary angioplasty. These patients had 
a defect previously documented with dipyridamole administra- 
tion on thallium-201 single-photon emission computed tomog- 
raphy (SPECT) imaging. Our aim was to document that this 
defect had been caused by flow inhomogeneity. 
Methods  
Study patients. Seventeen patients (15 men, 2 women; 
mean age [_+SD] 57 _+ 9 years, range 41 to 77) who were under- 
going elective coronary angioplasty because of stable angina 
pectoris refractory to medical treatment and lumen diameter 
stenosis ---50% in the left anterior descending coronary artery 
with a normal adjacent left circumflex coronary artery were 
prospectively studied (Table 1). All patients had shown revers- 
ible perfusion defects on thallium-201 scintigraphy, after intra- 
venous administration f dipyridamole performed within 24 to 
48 h before angioplasty. None had a clinical history or elec- 
trocardiographic (ECG) signs of a previous myocardial infarc- 
tion, history of systemic hypertension (arterial pressure 
->150/95 mm Hg) or evidence of primary myocardial or 
valvular heart disease. No patient had anemia (hemoglobin 
level <10.0 g/dl) or evidence of left ventricular hypertrophy 
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Table 1. Demographic Thallium-201 Imaging and Angiographic Characteristics of Study Patients 
T1-201 Scintigraphy 
Stenosis Dipyridamole Infusion LADtLCx Ratio 
Pt Age (yr)/ MLD Diam ~ ST (counts/pixel) TI-201 
No. Gender (mm) (%) AP >0.1 mV (ECG) Hyperemia Rest RPR 
1 60/M 0.21 90 No No 0.58 0.68 0.85 
2 52/M 0.82 68 No No 0.31 0.81 0.38 
3 58/M 0.64 80 No No 0.41 0.66 0.62 
4 43/M 0.08 97 No No 0.64 0.65 0.98 
5 51/M 0.36 87 Yes No 0.28 0.78 0.36 
6 41/M 0.51 83 Yes No 0.36 0.72 0.50 
7 58/F 0.43 85 Yes Yes 0.41 0.76 0.54 
8 74/M 0.57 82 No No 0.36 0.93 0.39 
9 63/M 0.35 86 No Yes 0.37 0.93 0.40 
10 49/M 0.25 90 Yes No 0.56 0.85 0.66 
11 54/F 0.35 89 Yes No 0.53 0.75 0.71 
12 77/M 0.28 88 No No 0.62 0.91 0.68 
13 56/M 0.12 95 No No 0.66 0.73 0.90 
14 56/M 0.17 94 Yes Yes 0.50 0.78 0.64 
15 62/M 1.35 55 No Yes 0.30 0.72 0.42 
16 57/M 0.12 94 Yes Yes 0.54 0.64 0.84 
17 65/M 0.36 84 Yes No 0.68 0.98 0.69 
Mean 57 0.41 85.12 0.48 0.78 0.62 
_+SD 9 0.31 10.35 0.14 0.11 0.20 
AP - angina pectoris; Diam = percent diameter stenosis; ECG = electrocardiogram; F = female; LAD - left 
anterior descending coronary artery; LCx = left circumflex coronary artery; M = male; MLD = minimal lumen diameter; 
Pt = patient; RPR = relative per:fusion ratio; $ ST = ST segment depression; TI-201 = thallium-201. 
(septal or posterior wall thickness >11 mm) on echocardio- 
graphic examination. Completely occluded vessels were ex- 
cluded from the study. No patient had angiographically visible 
collateral flow to the stenosed artery territory or evidence of 
thrombus at the stenosed artery. Cardiac medications were 
interrupted 1 day before the study, and drugs or foods con- 
taining methylxanthine compounds were withheld for at least 
18 h. No patient received narcotic medications for analgesia or 
atropine before the procedure. Intracoronary nitrates (200/~g) 
were administered before dipyridamole infusion to abolish the 
epicardial vasodilator action of the drug. The study protocol 
was approved by the Ethics Committee of our institution, and 
all patients gave written informed consent o the study. 
Catheterization procedure. After systemic anticoagulation 
with 10,000 IU of heparin administered intravenously, the left 
main stem was cannulated with an 8F giant lumen Judkins 
guiding catheter (Cordis Inc.). A 0.014-in. (0.36-mm) Doppler 
angioplasty guide wire was advanced to a segment of the left 
anterior descending coronary artery 5 to 10 artery diameters 
beyond the stenosis. A second 0.014-in. Doppler guide wire 
was positioned in the normal proximal or midsegment of the 
adjacent circumflex artery. Care was taken to avoid deep 
cannulation of the guiding catheter into the left coronary 
artery to prevent limitation of flow during maximal hyperemia. 
Heart rate, surface ECG (leads I, aVE, Vs) and aortic blood 
pressure as obtained from the guiding catheter were continu- 
ously recorded on a multichannel recorder. After baseline 
acquisition of flow velocity, heart rate and arterial pressure for 
a time interval of 5 min, dipyridamole was administered with a 
controlled-infusion pump system in the standard ose of 0.56 
mg/kg body weight intravenously over a period of 4 min. The 
changes in coronary flow velocity and hemodynamic measure- 
ments were obtained simultaneously in both arteries every 
2 min for a total time period of 10 min. The contrast medium 
used in all patients was ioxaglate sodium (Hexabrix R). Care 
was taken to withhold any contrast injection for 5 rain before 
flow measurements. All angiograms were reviewed by two 
experienced interventional cardiologists (V.V., A.M.). The 
lumen diameter of the stenosed artery at the proximal and 
distal segments and at the site of the stenosis, in the projection 
showing the maximal severity, was measured at end-diastole 
using electronic alipers. The dimension of the guiding cathe- 
ter was used to correct for differences in magnification. Anal- 
ysis of intraobserver and interobserver variability for the 
measurement of the coronary artery diameter with this tech- 
nique showed high reproducibility (r = 0.99, SEE 0.06, p < 
0.01 and r = 0.98, SEE 0.05, p < 0.01, respectively). 
Doppler guide wire and coronary flow velocity measure- 
ments. The Doppler angioplasty guide wire is 0.014-in., 
175 cm long, flexible and steerable, with a 15-MHz piezoelec- 
tric ultrasound transducer integrated on the tip (FloWire, 
Cardiometrics Inc.). The ultrasound beam diverges at 28 ° from 
the Doppler transducer, and the sample volume was positioned 
at a distance of 4.2 mm from the transducer to avoid the area 
of distortion of flow profile caused by the presence of the guide 
wire. The signal transmitted from the piezoelectric transducer 
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is processed from the Doppler audio signal by a real-time 
spectral analyzer using on-line fast Fourier transform algo- 
rithm (FloMap, Cardiometrics Inc.). This system displays 
several spectral variables on-line, including the time-averaged 
peak velocity (mean of 2 beats in cm/s) and the diastolic/ 
systolic velocity ratio. Velocity data are recorded on 0.5-in. 
videotape, and single-frame images can be printed for off-line 
analysis. The Doppler guide wire has been validated uring 
intravascular measurements of coronary artery flow velocity by 
Doucctte t al. (18). The coronary flow velocity reserve was 
defined as the ratio between the time-averaged peak velocity at 
peak hyperemia and the time-averaged peak velocity at base- 
line. On the basis of previous tudies, both by Miller et al. (19) 
and in our own laboratory (50 measurements), normal coro- 
nary flow velocity reserve was defined as >2.0. The relative 
flow reserve was defined as the quotient of coronary flow 
velocity reserve at the distal segment of the stenotic vessel and 
coronary flow velocity reserve at the adjacent normal vessel. 
Thallium.201 seintigraphy. All patients underwent dipyri- 
damole-thallium-201 scintigraphy 24 to 48 h before angioplasty 
(20,21). Dipyridamole was infused intravenously at the standard 
dose of 0.56 mg/kg over 4 rain. At the completion of the infusion, 
3 mCi of thallium was injected. Five to 10 rain after thallium-201 
injection, the patient was brought to a supine position, and 
imaging was started. During the first 20 min, the ECG, blood 
pressure and heart rate were recorded every minute. Thallium- 
201 scintigraphy was performed using a large field of view rotating 
gamma camera (Orbiter Siemens) equipped with a low energy, 
high resolution collimator interfaced to a computer (ICON). 
Thirty-two frames were obtained over a 180 °arc, from the 45 ° left 
posterior oblique to the 45 ° right anterior oblique position, at 6 ° 
intervals, for 40 s/frame. The data were stored on 64 × 64 × 
8-byte matr~ Imaging was repeated 4 h later to assess defect 
reversibility (22,23). The myocardial segments and coronary ar- 
teries were matched with the following classification: septal and 
anterior segments corresponded tothe left anterior descending; 
inferior, inferoapical nd posterior segments to the right; and 
lateral segments othe left circumflex coronary arteries. Myocar- 
dial uptake of thallium-201 was also quantified using two- 
dimensional polar plots depicting the three-dimensional thallium 
distribution. The polar plots obtained for each individual patient 
were statistically connected with a normal data bank. Myocardial 
pixels with counts <2.5 SD from the mean values of the corre- 
sponding pixels in the normal data bank were considered abnor- 
mal and coded as such by the computer software. The thallium- 
201 relative perfusion ratio was defined as the ratio of the activity 
(counts/pixel) of the involved segments (anterior and septal) to 
uninvolved segment (lateral) during hyperemia, divided by the 
same ratio on the delayed images. 
Statistical analysis. All data are expressed as mean 
value _+ SD. Two-tailed paired and unpaired Student  tests 
were used to compare the significance of the differences 
between flow velocity measurements at baseline and after 
dipyridamole infusion. Analysis of variance for repeated mea- 
surements was used for simultaneous comparison of more than 
two mean values. A nonparametric test (Mann-Whitney rank 
test) was used to compare differences in the degree of the 
stenosis between patients with and without angina pectoris and 
ECG changes during dipyridamole infusion. Simple linear and 
nonlinear regression analysis was performed to correlate flow 
velocity variables, thallium-201 quantitative measurements and 
angiographic data. Statistical significance was defined at p < 
0.05. 
Resul ts  
All patients tudied had severe stenoses of the left anterior 
descending coronary artery. Mean percent diameter stenosis 
was 85.12 + 10.35%, with mean minimal umen diameter 
0.41 _+ 0.31 ram. The location of the stenosis was the proximal 
segment of the left anterior descending artery in 7 patients and 
the midsegment, after the origin of the first septal branch or a 
diagonal branch, in the remaining 10. Mean global ejection 
fraction at rest in the right anterior oblique projection was 
55.4 + 8.4%. 
Clinical, ECG and hemodynamic hanges during dipyrid- 
amole infusion. During catheterization, i travenous dipyrida- 
mole produced an increase in heart rate from 74 _+ 13 to 97 _+ 
16 beats/rain (p < 0.001). Mean aortic blood pressure de- 
creased from 103 _+ 15 to 95 - 18 mm Hg (p = NS), systolic 
pressure from 137 _+ 20 to 129 _+ 23 mm Hg (p = NS) and 
diastolic aortic pressure from 76 _+ 12 to 70 _+ 15 ram Hg (p = 
NS). The rate-pressure product was 10,329 _+ 2,376 mm 
Hg/min at baseline and 12,271 _+ 2,534 rnm Hg/min during 
maximal vasodilation (p < 0.001). Similarly, on thallium-201 
imaging, no significant difference was noted between mean 
aortic blood pressure at rest and during dipyridamole infusion 
(from 101 _ 14 to 96 _ 15 mm Hg), whereas heart rate was 
increased from 68 _+ 11 beats/rain at rest to 100 _+ 14 beats/rain 
during hyperemia (p < 0.001). More important, at rest and 
during maximal hyperemia, mean aortic blood pressure, heart 
rate and rate-pressure product did not differ significantly 
during thallium-201 seintigraphy and during catheterization. 
Electrocardiographic changes uggestive of isehemia (ST seg- 
ment depression >0.1 mV) were seen in five patients in lead 
Vs, and anginal pain occurred in eight patients during dipyr- 
idamole infusion. 
Regional coronary flow velocity measurements. At base- 
line, the time-averaged peak velocity at the segment distal to 
the stenosis was 7.24 _+ 3.7 cm/s, and that at the adjacent 
normal eft circumflex coronary artery 18.88 -+ 7.1 cnl/s (p < 
0.001). After dipyridamole administration, a small increase in 
blood flow velocity was observed at the segment distal to the 
stenosis (5.5 _+ 33.7%). In contrast, a large increase was 
observed after dipyridamole in the adjacent normal eft cir- 
cumflex coronary artery, with a more than twofold increase in 
flow velocity from baseline (162.4 +_ 39.8%) (Table 2, and Fig. 
1). In seven patients it actually decreased; this flow decrease 
was accompanied by anginal pain in four patients and ECG 
ischemic hanges in two. The coronary flow velocity reserve 
was significantly lower at the distal segment of the stenosed 
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Table 2. Flow Velocity Changes After Dipyridamole Infusion 
APV (cm/s) 
Coronary Flow 
Relative Baseline Hyperemia Velocity Reserve 
Pt Flow 
No. dLAD LCx dLAD LCx dLAD LCx Reserve 
1 5 17 4 54 0.80 3.18 0.25 
2 4 9 6 26 1.50 2.89 0.52 
3 6 16 7 44 1.17 2.75 0.43 
4 12 27 8 69 0.67 2.56 0.26 
5 3 28 4 68 1.33 2.43 0.55 
6 10 20 11 50 1.10 2.50 0.44 
7 14 14 20 45 1.43 3.21 0.45 
8 12 34 15 87 1.25 2.56 0.49 
9 9 22 13 57 1.44 2.59 0.56 
10 5 18 6 54 1.20 3.00 0.40 
11 7 22 6 46 0.86 2.09 0.41 
12 9 11 12 33 1.33 3.00 0.44 
13 3 28 2 89 0.67 3.18 0.21 
14 9 13 8 27 0.89 2.08 0.43 
15 10 17 13 38 1.30 2.24 0.58 
16 3 15 1.5 33 0.50 2.20 0.23 
17 2 10 1 22 0.50 2.20 0.23 
Mean 7.24 18.88 8.09 49.53 1.06 2.63 0.40 
_SD 3.7 7.1 5.2 19.9 0.34 0.39 0.12 
APV = time-averaged peak velocity; dLAD = distal segment of left anterior descending coronary artery; LCx = 
proximal/midsegment of adjacent normal left circumflex coronary artery; Pt = patient. 
artery than at the adjacent normal coronary artery (1.06 _+ 0.34 
vs. 2.63 + 0.39, p < 0.001). The diastolic/systolic velocity ratio 
did not change significantly from baseline to hyperemia either 
at the normal coronary artery (1.78 _+ 0.7 to 1.73 _+ 0.5) or at 
the segment distal to the stenosis (0.93 _+ 0.2 to 0.84 -+ 0.3). 
The time response of the flow velocity changes during dipyr- 
idamole infusion and at the following 6 rain is depicted in 
Figure 2. The maximal increase in flow velocity was seen 2 to 
4 min after completion of the dipyridamole infusion in both 
arteries. A significant flow velocity increase was obtained in the 
left circumflex artery (p < 0.001) in contrast to a nonsignificant 
change observed in the left anterior descending coronary 
artery. There was no difference in flow velocity variables at rest 
or after maximal hyperemia between patients with angina and 
without angina or in patients with and without ST segment 
depression i  lead V5 during dipyridamole infusion. 
Coronary flow velocity and angiographic correlations. At 
the segment distal to the stenosis, the time-averaged peak 
velocity and the diastolic/systolic velocity ratio at baseline and 
after maximal hyperemia did not correlate with the degree of 
the stenosis expressed as percent of vessel diameter. In con- 
trast, distal coronary flow velocity reserve showed a significant 
correlation with percent of vessel diameter stenosis (r = 
-0.66, p < 0.05, Fig. 3). A similar correlation was observed 
between relative flow reserve and degree of stenosis (r = 
-0.67, p < 0.05). No significant correlation was observed 
between distal coronary flow velocity reserve and the diastolic/ 
systolic velocity ratio at baseline or during hyperemia. 
Quantitative thallium-201 scintigraphy and correlation 
with flow velocity measurements. The quotient of mean num- 
ber of counts/pixel at the segment perfused by the stenotic 
vessel (anterior and septal) and the mean number of counts/ 
pixel at the segment perfused by the normal left circumflex 
coronary artery (lateral) was 0.48 + 0.14 at the peak effect of 
dipyridamole and 0.78 -+ 0.11 on the delayed images (p < 
0.001) (Table 1). A strong correlation was found between the 
relative flow reserve stimated by flow velocity measurements 
using the Flowires and the thallium-201 relative perfusion ratio 
derived from quantitative thallium scintigraphic measurements 
(r = 0.90, p < 0.001) (Fig. 4). A similarly strong correlation 
was observed between relative flow reserve and the ratio of 
eounts/pixel in the involved segment and counts/pixel in the 
uninvolved segment at peak hyperemia lone (r = 0.86, p < 
o.ool). 
Discuss ion  
In the present study two intracoronary Doppler-tipped 
guide wires were used to assess coronary flow velocity simul- 
taneously at two different sites, at rest and after intravenous 
infusion of dipyridamole. The time-averaged peak velocity, 
measured at the segment distal to the stenosis at rest, was 
lower than at the proximal/midsegment of the adjacent normal 
left circumflex coronary artery, a finding that has been previ- 
ously reported (12,24,25). The systemic effects of dipyridamole 
infusion were similar to those reported in other studies with a 
significant increase in heart rate and no significant changes in 
aortic blood pressure (26-28). More important, mean aortic 
blood pressure, heart rate and rate-pressure product did not 
differ significantly during thallium-201 scintigraphy and during 
catheterization. 
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C D Figure 1. A, Left coronary angiogram show- 
ing severe stenosis at the midsegment of the 
left anterior descending coronary artery. This 
vessel is instrumented with one Flowire posi- 
tioned distally to the lesion and a second one 
positioned at the proximal segment of the 
normal left circumflex coronary artery. B, 
Thallium-201 imaging demonstrating a pro- 
found anterior and anteroapical reversible 
perfusion abnormality. C and D, Flow velocity 
measurements in proximal left circumflex cor- 
onary artery (LCX) and distal left anterior 
descending coronary artery (LAD) after di- 
pyridamole infusion (C) and at baseline (D). 
Note the absence of flow velocity changes at 
the distal left anterior descending coronary 
artery, whereas the proximal left circumflex 
coronary artery the showed amarked increase 
in time-averaged peak velocity after dipyrid- 
amole infusion. D = diastole; S = systole. 
Coronary flow reserve. The quantitative flow velocity mea- 
surements in our patients during hyperemia demonstrate a 
lack of flow increase in a zone supplied by a stenotic vessel with 
simultaneous increase of flow to the zones perfused by a 
normal vessel. This is the first direct proof of flow inhomoge- 
neity produced by intravenous dipyridamole in normal and 
diseased coronary arteries. Normal coronary flow reserve 
derived indirectly using coronary angiography or positron 
emission tomography varies from 2.5 to 5.5 (29-32); by using 
Doppler catheters (3F), values ranged from 3.5 to 5.5 (14,28), 
contrary to those recorded using a Doppler guide wire, which 
yields values from 2.0 to 3.0 (24,25). In contrast, in the 
presence of a flow-limiting stenosis, the ability to achieve such 
a maximal augmentation in coronary flow after coronary 
vasodilation is limited, because resistance vessels have already 
undergone compensatory vasodilation in an attempt o main- 
tain flow (33). In previous tudies (34) using indirect methods, 
it has been shown that inequalities of regional myocardial 
perfusion may be detected with thallium-201 if hyperemic flow 
in normally perfused myocardium exceeds that in diseased 
regions by a factor of 2, a condition that was more than met in 
our study. 
Figure 2. Temporal changes in flow velocity during infusion of 
0.56 mg/kg of dipyridamole and over the succeeding 6 min at the 
segment distal to the stenosis (circles) and at the adjacent normal 
coronary artery (squares). APV = time-averaged peak velocity. 
6O 
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Figure 3. Simple regression a alysis of coronary flow velocity reserve 
(CFVR) at the segment distal to the stenosis and percent vessel 
diameter stenosis. Note a significant correlation over the entire range 
of measurements. 
.6- 
.3  
.2"  
i 
! . ..... . . 
r =0.90, p<O.O01 
.1 
.J 5 3 .,i .~ .~ 5 .~ .,~ ].'o 
Thal l ium-20! RPR 
Figure 4. Linear egression a alysis of the relative flow reserve (RFR) 
estimated with the Flowire and thallium-201 relative perfusion ratio 
(RPR) derived from thallium-201 quantitative measurements. A 
strong correlation (r = 0.90, p < 0.001) is present between these 
variables. 
Coronary "steal phenomenon." In seven of our patients a
decrease in the coronary flow velocity at peak hyperemia distal 
to the stenosis was observed. In these patients, the "steal 
phenomenon" can be postulated. Coronary steal (35-37) has 
been defined as an increase in flow to nonischemic myocar- 
dium at the expense of decreasing flow to ischemic myocar- 
dium (horizontal steal); another type of coronary steal, suben- 
docardial to subepicardial, has also been described (vertical 
steal). Both types may occur in a given patient, depending on 
the extent and severity of the coronary artery disease. Quan- 
titative demonstration f horizontal steal has remained elusive 
because of methodologic problems. In a previous report, Kern 
et al. (38) described a case in which steal across the stenosis has 
been confirmed using continuous dual Flowire spectral coro- 
nary flow measurements performed proximal and distal to the 
stenosis egment of the first marginal branch during intracoro- 
nary adenosine and intravenous dipyridamole infusions. 
Correlations between anatomic and physiologic data. We 
found a significant correlation between the severity of coronary 
artery stenosis, as expressed by the percent of the vessel 
diameter and poststenotic coronary flow velocity reserve. Sim- 
ilar results have been reported by Miller et al. (19) using the 
same technique. Nevertheless, some investigators (4,39) have 
reported a poor correlation between the effect of a stenosis on 
flow behavior and its anatomic haracteristics, and they have 
suggested that relative rather than absolute stimates of myo- 
cardial perfusion reserve might be a more sensitive descriptor 
of the physiologic onsequences of angiographic stenosis e- 
verity. Up to now these measurements of relative perfusion 
reserve have been performed with positron emission tomogra- 
phy using different tracers (30,40-42). In our study the percent 
vessel diameter stenosis howed a strong correlation with the 
relative flow reserve as well as with the poststenotic coronary 
flow velocity reserve. Another important finding of our study is 
the strong and very significant correlation observed between 
the relative flow reserve and the thallium-201 relative perfu- 
sion ratio derived by quantitative measurements on thallium- 
201 scintigraphy. This correlation still existed when the scinti- 
graphic activity during hyperemia lone was considered and 
has, to our knowledge, not been reported up to now. In a 
recent study, Joye et al. (43), in patients with intermediate 
coronary artery stenoses, found a perfusion defect in 15 of 16 
vascular territories with an abnormal coronary flow reserve, 
but only in 1 of 19 territories with a normal coronary flow 
reserve, although the degree of the stenosis was similar in the 
two groups. It is worth mentioning that in our patient group 
with severe coronary stenoses, the functional hemodynamic 
assessment with the Flowire correlates better with the scinti- 
graphic perfusion data than with the angiographically deter- 
mined severity of the stenosis. This may have implications in 
the a priori acceptance of coronary angiography as the refer- 
ence standard in the functional evaluation of patients with 
advanced coronary artery disease. 
Study limitations. Technical factors related to obtaining 
flow velocity measurements, such as potential aliasing effects 
and spectral analysis of the signal, are minor with this tech- 
nique and its large Doppler sample volume, but they still exist. 
The simultaneous e of two Flowires was satisfactory in our 
patients but may be compromised by signal interference or 
transient loss of signal as a result of wire rotation or motion 
artifact. 
Changes in coronary flow velocity during intravenous dipyr- 
idamole infusion may not reflect changes in volumetric flow if 
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the medication also alters the lumen diameter of the coronary 
artery at the site of Doppler measurements. No angiography 
was performed at the maximal effect of dipyridamole infusion 
in our study. However, previous tudies have demonstrated no
change or minimal changes in coronary diameter following 
intravenous adenosine or dipyridamole administration 
(24,28,44). Ogilby et al. (45) suggested that slight vasodilation 
may occur in both normal and stenotic segments; as a result, 
the percent diameter stenosis is not essentially altered. Thus, 
any increase in coronary flow velocity after dipyridamole 
infusion may not have essentially influenced our results. It is 
possible, however, that obstruction of the lesion by the Dopp- 
ler guide wire may have resulted in hyperemic flow reduction, 
although this guide wire has a minimal diameter (0.014 in.) 
compared with previously used Doppler catheters. In a recent 
study, De Bruyne et al. (46) have reported that in patients with 
isolated very tight stenoses of the left anterior descending 
artery and normal eft ventricular function, the presence of the 
pressure-monitoring guide wire (diameter 0.015-in. [0.38 mm]) 
through the lesion did not induce a large overestimation f the 
actual pressure gradient. 
Another limitation of the study is that the dose of dipyrid- 
amole used (0.56 mg/kg) may have produced submaximal 
vasodilation i  some patients. Evidence for submaximal coro- 
nary vasodilation after administration of dipyridamole in the 
standard dose of 0.56 mg/kg has been reported by other 
investigators (2,47). The hyperemic flow velocities in the 
normal coronary artery of our study group were similar to 
those previously reported (16,48). Furthermore, any submaxi- 
mal effect of dipyridamole infusion may have had a similar 
impact on the two studied arteries; this dose is the one most 
widely used in thallium-201 imaging studies, although larger 
doses are used during echocardiography. We did not perform 
a coronary flow reserve measurement using either intracoro- 
nary adenosine or papaverine for comparison before dipyrid- 
amole infusion. The comparison of dipyridamole with intra- 
coronary adenosine or papaverine hyperemia has been 
reported, and in general adenosine achieves imilar maximal 
flow velocities to dipyridamole in normal vessels (40,49). 
Finally, we used hand-held electronic alipers to measure the 
degree of coronary artery stenosis. Although this technique, 
for stenoses >80% diameter narrowing, is fraught with tech- 
nical difficulties, strong intraobserver and interobserver vari- 
ability has been reported (50). 
Conclusions. Flow inhomogeneity was documented in se- 
lected patients with Severe stenoses of the left anterior de- 
scending and normal eft circumflex coronary arteries by direct 
flow velocity measurements, corresponding tothallium defects. 
A low poststenotic flow velocity reserve coupled with a normal 
coronary flow velocity reserve in an adjacent unaffected zone 
of myocardium does represent he mechanism by which 
dipyridamole-thallium scanning results are positive. The issue 
regarding whether this represents rue isehemia or not cannot 
be addressed by this study. 
We are indebted to Helen Kyrozi for statistical advice. 
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